244 related articles for article (PubMed ID: 16442693)
1. Proliferative activity of early ovarian clear cell adenocarcinoma depends on association with endometriosis.
Komiyama S; Aoki D; Katsuki Y; Nozawa S
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):130-6. PubMed ID: 16442693
[TBL] [Abstract][Full Text] [Related]
2. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.
Ogawa S; Kaku T; Amada S; Kobayashi H; Hirakawa T; Ariyoshi K; Kamura T; Nakano H
Gynecol Oncol; 2000 May; 77(2):298-304. PubMed ID: 10785482
[TBL] [Abstract][Full Text] [Related]
3. [The biological property of ovarian cancers is affected by endometriosis--with special reference to ovarian clear cell adenocarcinoma].
Aoki D; Komiyama S; Susumu N; Nozawa S
Nihon Rinsho; 2001 Jan; 59 Suppl 1():213-6. PubMed ID: 11235169
[No Abstract] [Full Text] [Related]
4. Clear cell adenocarcinoma associated with clear cell adenofibromatous components: a subgroup of ovarian clear cell adenocarcinoma with distinct clinicopathologic characteristics.
Yamamoto S; Tsuda H; Yoshikawa T; Kudoh K; Kita T; Furuya K; Tamai S; Matsubara O
Am J Surg Pathol; 2007 Jul; 31(7):999-1006. PubMed ID: 17592265
[TBL] [Abstract][Full Text] [Related]
5. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
6. Rapid growth of an ovarian clear cell carcinoma expressing LH/hCG receptor arising from endometriosis during early pregnancy.
Kobayashi F; Monma C; Nanbu K; Konishi I; Sagawa N; Mori T
Gynecol Oncol; 1996 Aug; 62(2):309-13. PubMed ID: 8751567
[TBL] [Abstract][Full Text] [Related]
7. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
8. Ovarian clear cell carcinoma with papillary features: a potential mimic of serous tumor of low malignant potential.
Sangoi AR; Soslow RA; Teng NN; Longacre TA
Am J Surg Pathol; 2008 Feb; 32(2):269-74. PubMed ID: 18223330
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of two human ovarian clear cell adenocarcinoma lines from metastatic lesions with different properties.
Gorai I; Nakazawa T; Miyagi E; Hirahara F; Nagashima Y; Minaguchi H
Gynecol Oncol; 1995 Apr; 57(1):33-46. PubMed ID: 7535723
[TBL] [Abstract][Full Text] [Related]
10. [Clinical discussion of the relationship between endometriosis and epithelial ovarian cancer].
Zhang Y; Huang H; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):544-6. PubMed ID: 11360640
[TBL] [Abstract][Full Text] [Related]
11. Cystic and adenofibromatous clear cell carcinomas of the ovary: distinctive tumors that differ in their pathogenesis and behavior: a clinicopathologic analysis of 122 cases.
Veras E; Mao TL; Ayhan A; Ueda S; Lai H; Hayran M; Shih IeM; Kurman RJ
Am J Surg Pathol; 2009 Jun; 33(6):844-53. PubMed ID: 19342944
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of endometriosis in clear cell carcinoma of the ovary.
Orezzoli JP; Russell AH; Oliva E; Del Carmen MG; Eichhorn J; Fuller AF
Gynecol Oncol; 2008 Sep; 110(3):336-44. PubMed ID: 18639330
[TBL] [Abstract][Full Text] [Related]
13. Endometrioid adenocarcinoma of the ovary and endometriosis.
Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
[TBL] [Abstract][Full Text] [Related]
14. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type.
Silva EG; Young RH
Am J Surg Pathol; 2007 Aug; 31(8):1203-8. PubMed ID: 17667544
[TBL] [Abstract][Full Text] [Related]
15. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations.
Katz E; Skorecki K; Tzukerman M
Clin Cancer Res; 2009 Jan; 15(1):70-80. PubMed ID: 19118034
[TBL] [Abstract][Full Text] [Related]
16. [Establishment and comparison of two intraperitoneally transplanted human ovarian carcinoma models with immune reconstitution in severe combined immunodeficient mice].
Li Y; Cui H; Chang XH; Feng J; Fu TY; Feng YJ; Wei LH
Ai Zheng; 2004 Feb; 23(2):160-4. PubMed ID: 14960235
[TBL] [Abstract][Full Text] [Related]
17. Characterization of human ovarian carcinomas in a SCID mouse model.
Xu Y; Silver DF; Yang NP; Oflazoglu E; Hempling RE; Piver MS; Repasky EA
Gynecol Oncol; 1999 Feb; 72(2):161-70. PubMed ID: 10021295
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of clear cell ovarian cancer arising from endometriosis: a two center cohort study.
Scarfone G; Bergamini A; Noli S; Villa A; Cipriani S; Taccagni G; Vigano' P; Candiani M; Parazzini F; Mangili G
Gynecol Oncol; 2014 Jun; 133(3):480-4. PubMed ID: 24642093
[TBL] [Abstract][Full Text] [Related]
19. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis.
Hirabayashi K; Yasuda M; Osamura RY; Hirasawa T; Murakami M
Gynecol Oncol; 2006 Jul; 102(1):111-7. PubMed ID: 16527336
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer.
Landen CN; Lu C; Han LY; Coffman KT; Bruckheimer E; Halder J; Mangala LS; Merritt WM; Lin YG; Gao C; Schmandt R; Kamat AA; Li Y; Thaker P; Gershenson DM; Parikh NU; Gallick GE; Kinch MS; Sood AK
J Natl Cancer Inst; 2006 Nov; 98(21):1558-70. PubMed ID: 17077358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]